Bieber Katja

Publikationen

Publikationen pro Jahr 2005 2017 2020 2021 2022 2023 2024

• 61 Zeitschriftenaufsätze
• 14 Übersichtsarbeiten
• 3 Kommentare/Debatten
• 2 Briefe
• 2 Mehr
  • 1 Kapitel
  • 1 Leitartikel

Publikationen pro Jahr

Publikationen pro Jahr

Suchergebnisse

• 2018

  Regulatory T-cell deficiency leads to pathogenic bullous pemphigoid antigen 230 autoantibody and autoimmune bullous disease

  Haeberle, S., Wei, X., Bieber, K., Goletz, S., Ludwig, R. J., Schmidt, E., Enk, A. H. & Hadaschik, E. N., 01.01.2018, in: Journal of Allergy and Clinical Immunology.

  Publikation: Beiträge in Fachzeitschriften › Zeitschriftenaufsätze › Forschung › Begutachtung

  • Bullous Pemphigoid 100%
  • Vesiculobullous Skin Diseases 81%
  • Regulatory T-Lymphocytes 76%
  • Autoantibodies 71%
  • Autoimmune Diseases 66%

• Therapeutic effect of a novel phosphatidylinositol-3-Kinase δ inhibitor in experimental epidermolysis bullosa acquisita

  Koga, H., Kasprick, A., López, R., Aulí, M., Pont, M., Godessart, N., Zillikens, D., Bieber, K., Ludwig, R. J. & Balagué, C., 12.07.2018, in: Frontiers in Immunology. 9, JUL, 12 S., 1558.

  Publikation: Beiträge in Fachzeitschriften › Zeitschriftenaufsätze › Forschung › Begutachtung

  • Epidermolysis Bullosa Acquisita 100%
  • Phosphatidylinositol 3-Kinase 64%
  • Therapeutic Uses 52%
  • B-Lymphocytes 16%
  • Antigen-Antibody Complex 14%

• Whole-genome expression profiling in skin reveals SYK As a key regulator of inflammation in experimental epidermolysis bullosa acquisita

  Samavedam, U. K., Mitschker, N., Kasprick, A., Bieber, K., Schmidt, E., Laskay, T., Recke, A., Goletz, S., Vidarsson, G., Schulze, F. S., Armbrust, M., Dieckhoff, K. S., Pas, H. H., Jonkman, M. F., Kalies, K., Zillikens, D., Gupta, Y., Ibrahim, S. M. & Ludwig, R. J., 15.02.2018, in: Frontiers in Immunology. 9, FEB, 249.

  Publikation: Beiträge in Fachzeitschriften › Zeitschriftenaufsätze › Forschung › Begutachtung

  • Epidermolysis Bullosa Acquisita 100%
  • Syk Kinase 92%
  • Genome 43%
  • Inflammation 37%
  • Skin 34%
• 2017

  Analysis of serum markers of cellular immune activation in patients with bullous pemphigoid

  Bieber, K., Ernst, A. L., Tukaj, S., Holtsche, M. M., Schmidt, E., Zillikens, D., Ludwig, R. J. & Kasperkiewicz, M., 01.12.2017, in: Experimental Dermatology. 26, 12, S. 1248-1252 5 S.

  Publikation: Beiträge in Fachzeitschriften › Zeitschriftenaufsätze › Forschung › Begutachtung

  • Bullous Pemphigoid 100%
  • Tryptases 50%
  • Biomarkers 50%
  • P-Selectin 46%
  • S100A12 Protein 31%
  5 Zitate (Scopus)

• CCL3/MIP1α represents a biomarker but not a mandatory cytokine for disease development in experimental epidermolysis bullosa acquisita

  Kasperkiewicz, M., Kalies, K., Pagel, R., Bieber, K., Zillikens, D. & Ludwig, R. J., 01.11.2017, in: Journal of Dermatological Science. 88, 2, S. 248-250 3 S.

  Publikation: Beiträge in Fachzeitschriften › Briefe › Begutachtung

• Evidence for a contributory role of a xenogeneic immune response in experimental epidermolysis bullosa acquisita

  Niebuhr, M., Kasperkiewicz, M., Maass, S., Hauenschild, E., Bieber, K., Ludwig, R. J., Westermann, J. & Kalies, K., 01.12.2017, in: Experimental Dermatology. 26, 12, S. 1207-1213 7 S.

  Publikation: Beiträge in Fachzeitschriften › Zeitschriftenaufsätze › Forschung › Begutachtung

  • Epidermolysis Bullosa Acquisita 100%
  • Rabbits 18%
  • Immunoglobulin G 15%
  • B-Lymphocytes 12%
  • anti-IgG 11%
  3 Zitate (Scopus)

• Increased TREM-1 expression in inflamed skin has no functional impact on the pathogenesis of cutaneous disorders

  Dräger, S., Kalies, K., Sidronio, T. B., Witte, M., Ludwig, R. J. & Bieber, K., 01.10.2017, in: Journal of Dermatological Science. 88, 1, S. 152-155 4 S.

  Publikation: Beiträge in Fachzeitschriften › Briefe › Begutachtung

• In vitro and in vivo models to investigate the pathomechanisms and novel treatments for pemphigoid diseases

  Bieber, K., Koga, H. & Nishie, W., 12.2017, in: Experimental Dermatology. 26, 12, S. 1163-1170 8 S.

  Publikation: Beiträge in Fachzeitschriften › Übersichtsarbeiten › Forschung

  • Bullous Pemphigoid 100%
  • Autoantibodies 47%
  • Blister 40%
  • Skin 35%
  • In Vitro Techniques 33%
  29 Zitate (Scopus)

• Mechanisms of Autoantibody-Induced Pathology

  Ludwig, R. J., Vanhoorelbeke, K., Leypoldt, F., Kaya, Z., Bieber, K., McLachlan, S. M., Komorowski, L., Luo, J., Cabral-Marques, O., Hammers, C. M., Lindstrom, J. M., Lamprecht, P., Fischer, A., Riemekasten, G., Tersteeg, C., Sondermann, P., Rapoport, B., Wandinger, K. P., Probst, C., Beidaq, A. E., &4 mehrSchmidt, E., Verkman, A., Manz, R. A. & Nimmerjahn, F., 31.05.2017, in: Frontiers in Immunology. 8, MAY, S. 603

  Publikation: Beiträge in Fachzeitschriften › Übersichtsarbeiten › Forschung

  • Autoantibodies 100%
  • Pathology 68%
  • Autoimmune Diseases 23%
  • Neutrophil Activation 17%
  • Graves Disease 15%
  37 Zitate (Scopus)

• Regulatory T cells suppress inflammation and blistering in pemphigoid diseases

  Bieber, K., Sun, S., Witte, M., Kasprick, A., Beltsiou, F., Behnen, M., Laskay, T., Schulze, F. S., Pipi, E., Reichhelm, N., Pagel, R., Zillikens, D., Schmidt, E., Sparwasser, T., Kalies, K. & Ludwig, R. J., 24.11.2017, in: Frontiers in Immunology. 8, NOV, 1628.

  Publikation: Beiträge in Fachzeitschriften › Zeitschriftenaufsätze › Forschung › Begutachtung

  • Bullous Pemphigoid 100%
  • Myeloid Cells 78%
  • Regulatory T-Lymphocytes 76%
  • Inflammation 45%
  • Antigen-Antibody Complex 19%
  2 Zitate (Scopus)

• The Leukotriene B₄ and its Receptor BLT1 Act as Critical Drivers of Neutrophil Recruitment in Murine Bullous Pemphigoid-Like Epidermolysis Bullosa Acquisita

  Sezin, T., Krajewski, M., Wutkowski, A., Mousavi, S., Chakievska, L., Bieber, K., Ludwig, R. J., Dahlke, M., Rades, D., Schulze, F. S., Schmidt, E., Kalies, K., Gupta, Y., Schilf, P., Ibrahim, S. M., König, P., Schwudke, D., Zillikens, D. & Sadik, C. D., 01.05.2017, in: Journal of Investigative Dermatology. 137, 5, S. 1104-1113 10 S.

  Publikation: Beiträge in Fachzeitschriften › Zeitschriftenaufsätze › Forschung › Begutachtung

  • Leukotriene B4 Receptors 100%
  • Epidermolysis Bullosa Acquisita 98%
  • Bullous Pemphigoid 81%
  • Neutrophil Infiltration 71%
  • Leukotriene B4 38%
  6 Zitate (Scopus)

• Topically Applied Hsp90 Blocker 17AAG Inhibits Autoantibody-Mediated Blister-Inducing Cutaneous Inflammation

  Tukaj, S., Bieber, K., Kleszczyński, K., Witte, M., Cames, R., Kalies, K., Zillikens, D., Ludwig, R. J., Fischer, T. W. & Kasperkiewicz, M., 01.02.2017, in: Journal of Investigative Dermatology. 137, 2, S. 341-349 9 S.

  Publikation: Beiträge in Fachzeitschriften › Zeitschriftenaufsätze › Forschung › Begutachtung

  • Epidermolysis Bullosa Acquisita 100%
  • Blister 83%
  • Autoantibodies 73%
  • Inflammation 46%
  • Skin 43%
  2 Zitate (Scopus)
• 2016

  Dimethylfumarate impairs neutrophil functions

  Müller, S., Behnen, M., Bieber, K., Möller, S., Hellberg, L., Witte, M., Hänsel, M., Zillikens, D., Solbach, W., Laskay, T. & Ludwig, R. J., 01.01.2016, in: Journal of Investigative Dermatology. 136, 1, S. 117-126 10 S.

  Publikation: Beiträge in Fachzeitschriften › Zeitschriftenaufsätze › Forschung › Begutachtung

  • Dimethyl Fumarate 100%
  • Neutrophils 50%
  • Neutrophil Activation 40%
  • Epidermolysis Bullosa Acquisita 25%
  • Collagen Type VII 24%
  11 Zitate (Scopus)

• Discovering potential drug-targets for personalized treatment of autoimmune disorders - what we learn from epidermolysis bullosa acquisita

  Witte, M., Koga, H., Hashimoto, T., Ludwig, R. J. & Bieber, K., 02.08.2016, in: Expert Opinion on Therapeutic Targets. 20, 8, S. 985-998 14 S.

  Publikation: Beiträge in Fachzeitschriften › Übersichtsarbeiten › Forschung

  • Epidermolysis Bullosa Acquisita 100%
  • Pharmaceutical Preparations 26%
  • Therapeutics 10%
  • Disease Progression 10%
  • Vesiculobullous Skin Diseases 9%
  8 Zitate (Scopus)

• Epidermolysis bullosa acquisita: From pathophysiology to novel therapeutic options

  Kasperkiewicz, M., Sadik, C. D., Bieber, K., Ibrahim, S. M., Manz, R. A., Schmidt, E., Zillikens, D. & Ludwig, R. J., 01.01.2016, in: Journal of Investigative Dermatology. 136, 1, S. 24-33 10 S.

  Publikation: Beiträge in Fachzeitschriften › Übersichtsarbeiten › Forschung

  • Epidermolysis Bullosa Acquisita 100%
  • Autoantibodies 58%
  • Bullous Pemphigoid 41%
  • Autoimmune Diseases 27%
  • Collagen Type VII 24%
  25 Zitate (Scopus)

• In vivo expansion of endogenous regulatory t cell populations induces long-term suppression of contact hypersensitivity

  El Beidaq, A., Link, C. W. M., Hofmann, K., Frehse, B., Hartmann, K., Bieber, K., Martin, S. F., Ludwig, R. J. & Manz, R. A., 01.09.2016, in: Journal of Immunology. 197, 5, S. 1567-1576 10 S.

  Publikation: Beiträge in Fachzeitschriften › Zeitschriftenaufsätze › Forschung › Begutachtung

  • Contact Dermatitis 100%
  • Interleukin-2 75%
  • Haptens 60%
  • Population 33%
  • T-Lymphocytes 30%
  2 Zitate (Scopus)

• Reduced skin blistering in experimental epidermolysis bullosa acquisita after anti-TNF treatment

  Hirose, M., Kasprick, A., Beltsiou, F., Dieckhoff, K. S., Schulze, F. S., Samavedam, U. K. J. S. R. L., Hundt, J. E., Pas, H. H., Jonkman, M. F., Schmidt, E., Kalies, K., Zillikens, D., Ludwig, R. J. & Bieber, K., 20.12.2016, in: Molecular Medicine. 22, S. 918-926 9 S.

  Publikation: Beiträge in Fachzeitschriften › Zeitschriftenaufsätze › Forschung › Begutachtung

  • Epidermolysis Bullosa Acquisita 100%
  • Tumor Necrosis Factor-alpha 45%
  • Etanercept 35%
  • Skin 34%
  • Collagen Type VII 21%
  9 Zitate (Scopus)

• Skin microbiota-associated inflammation precedes autoantibody induced tissue damage in experimental epidermolysis bullosa acquisita

  Ellebrecht, C. T., Srinivas, G., Bieber, K., Banczyk, D., Kalies, K., Künzel, S., Hammers, C. M., Baines, J. F., Zillikens, D., Ludwig, R. J. & Westermann, J., 01.04.2016, in: Journal of Autoimmunity. 68, S. 14-22 9 S.

  Publikation: Beiträge in Fachzeitschriften › Zeitschriftenaufsätze › Forschung › Begutachtung

  • Epidermolysis Bullosa Acquisita 100%
  • Microbiota 62%
  • Autoantibodies 58%
  • Immunization 38%
  • Inflammation 37%
  5 Zitate (Scopus)

• T cells mediate autoantibody-induced cutaneous inflammation and blistering in epidermolysis bullosa acquisita

  Bieber, K., Witte, M., Sun, S., Hundt, J. E., Kalies, K., Dräger, S., Kasprick, A., Twelkmeyer, T., Manz, R. A., König, P., Köhl, J., Zillikens, D. & Ludwig, R. J., 05.12.2016, in: Scientific Reports. 6, 38357.

  Publikation: Beiträge in Fachzeitschriften › Zeitschriftenaufsätze › Forschung › Begutachtung

  • Epidermolysis Bullosa Acquisita 100%
  • Autoantibodies 58%
  • T-Lymphocytes 39%
  • Inflammation 37%
  • Skin 34%
  8 Zitate (Scopus)
• 2015

  Animal models to investigate pathomechanisms and evaluate novel treatments for autoimmune bullous dermatoses

  Iwata, H., Bieber, K., Hirose, M. & Ludwig, R. J., 01.05.2015, in: Current Pharmaceutical Design. 21, 18, S. 2422-2439 18 S.

  Publikation: Beiträge in Fachzeitschriften › Zeitschriftenaufsätze › Forschung › Begutachtung

  • Vesiculobullous Skin Diseases 100%
  • Animal Models 47%
  • Therapeutics 10%
  • Autoantibodies 9%
  • Epidermolysis Bullosa Acquisita 8%
  15 Zitate (Scopus)

• A recombinant fusion protein derived from dog hookworm inhibits autoantibody-induced dermal-epidermal separation ex vivo

  Kemmer, A., Bieber, K., Abadpour, A., Yu, X., Mitschker, N., Roth, S., Kauderer, C., Ludwig, R. J., Seeger, K., Köhl, J., Zillikens, D. & Recke, A., 01.11.2015, in: Experimental Dermatology. 24, 11, S. 872-878 7 S.

  Publikation: Beiträge in Fachzeitschriften › Zeitschriftenaufsätze › Forschung › Begutachtung

• The retinoid-related orphan receptor alpha is essential for the end-stage effector phase of experimental epidermolysis bullosa acquisita

  Sadeghi, H., Gupta, Y., Möller, S., Samavedam, U. K., Behnen, M., Kasprick, A., Bieber, K., Müller, S., Kalies, K., de Castro Marques, A., Recke, A., Schmidt, E., Zillikens, D., Laskay, T., Mariani, J., Ibrahim, S. M. & Ludwig, R. J., 09.2015, in: American Journal of Pathology. 237, 1, S. 111-22 12 S.

  Publikation: Beiträge in Fachzeitschriften › Zeitschriftenaufsätze › Forschung › Begutachtung

  • Nuclear Receptor Subfamily 1, Group F, Member 1 100%
  • Epidermolysis Bullosa Acquisita 81%
  • Haplotypes 36%
  • anti-IgG 29%
  • Collagen Type VII 19%
• 2013

  B cells, dendritic cells, and macrophages are required to induce an autoreactive CD4 helper T cell response in experimental epidermolysis bullosa acquisita

  Iwata, H., Bieber, K., Tiburzy, B., Chrobok, N., Kalies, K., Shimizu, A., Leineweber, S., Ishiko, A., Vorobyev, A., Zillikens, D., Köhl, J., Westermann, J., Seeger, K., Manz, R. & Ludwig, R. J., 15.09.2013, in: Journal of Immunology. 191, 6, S. 2978-2988 11 S.

  Publikation: Beiträge in Fachzeitschriften › Zeitschriftenaufsätze › Forschung › Begutachtung

  • Epidermolysis Bullosa Acquisita 100%
  • Helper-Inducer T-Lymphocytes 65%
  • Autoantibodies 58%
  • Dendritic Cells 56%
  • B-Lymphocytes 48%
  26 Zitate (Scopus)
• 2011

  Complement-fixing anti-type VII collagen antibodies are induced in Th1-polarized lymph nodes of epidermolysis bullosa acquisita-susceptible mice

  Hammers, C. M., Bieber, K., Kalies, K., Banczyk, D., Ellebrecht, C. T., Ibrahim, S. M., Zillikens, D., Ludwig, R. J. & Westermann, J., 15.11.2011, in: Journal of Immunology. 187, 10, S. 5043-5050 8 S.

  Publikation: Beiträge in Fachzeitschriften › Zeitschriftenaufsätze › Forschung › Begutachtung

  • Epidermolysis Bullosa Acquisita 100%
  • Collagen Type VII 97%
  • Lymph Nodes 45%
  • Antibodies 35%
  • Autoantibodies 29%
  25 Zitate (Scopus)

• Generation of antibodies of distinct subclasses and specificity is linked to H2s in an active mouse model of epidermolysis bullosa acquisita

  Ludwig, R. J., Recke, A., Bieber, K., Müller, S., Marques, A. D. C., Banczyk, D., Hirose, M., Kasperkiewicz, M., Ishii, N., Schmidt, E., Westermann, J., Zillikens, D. & Ibrahim, S. M., 01.2011, Journal of Investigative Dermatology. S. 167-176 10 S. (Journal of Investigative Dermatology; Band 131).

  Publikation: Kapitel in Büchern/Berichten/Konferenzbänden › Kapitel › Begutachtung

  • Epidermolysis Bullosa Acquisita 100%
  • Antibodies 35%
  • Major Histocompatibility Complex 24%
  • Haplotypes 14%
  • Autoantibodies 14%

• Repetitive immunization breaks tolerance to type XVII collagen and leads to bullous pemphigoid in mice

  Hirose, M., Recke, A., Beckmann, T., Shimizu, A., Ishiko, A., Bieber, K., Westermann, J., Zillikens, D., Schmidt, E. & Ludwig, R. J., 01.08.2011, in: Journal of Immunology. 187, 3, S. 1176-1183 8 S.

  Publikation: Beiträge in Fachzeitschriften › Zeitschriftenaufsätze › Forschung › Begutachtung

  • collagen type XVII 100%
  • Bullous Pemphigoid 78%
  • Immunization 50%
  • Autoantibodies 31%
  • Immunodominant Epitopes 11%
  38 Zitate (Scopus)

• TNF receptor-1 is required for the formation of splenic compartments during adult, but not embryonic life

  Milićević, N. M., Klaperski, K., Nohroudi, K., Milićević, Ž., Bieber, K., Baraniec, B., Blessenohl, M., Kalies, K., Ware, C. F. & Westermann, J., 01.02.2011, in: Journal of Immunology. 186, 3, S. 1486-1494 9 S.

  Publikation: Beiträge in Fachzeitschriften › Zeitschriftenaufsätze › Forschung › Begutachtung

  • Lymphotoxin-alpha 100%
  • Tumor Necrosis Factor Receptors 87%
  • Lymphoid Tissue 32%
  • Tertiary Lymphoid Structures 25%
  • Spleen 23%
  14 Zitate (Scopus)
• 2010

  Animal models for autoimmune bullous dermatoses

  Bieber, K., Sun, S., Ishii, N., Kasperkiewicz, M., Schmidt, E., Hirose, M., Westermann, J., Yu, X., Zillikens, D. & Ludwig, R. J., 01.01.2010, in: Experimental Dermatology. 19, 1, S. 2-11 10 S.

  Publikation: Beiträge in Fachzeitschriften › Übersichtsarbeiten › Forschung

  • Vesiculobullous Skin Diseases 100%
  • Animal Models 47%
  • Blister 34%
  • Skin Diseases 31%
  • Mucous Membrane 26%
  21 Zitate (Scopus)

• The CD40-CD40L Pathway contributes to the proinflammatory function of intestinal epithelial cells in inflammatory bowel disease

  Borcherding, F., Nitschke, M., Hundorfean, G., Rupp, J., Von Smolinski, D., Bieber, K., Van Kooten, C., Lehnert, H., Fellermann, K. & Büning, J., 01.01.2010, in: American Journal of Pathology. 176, 4, S. 1816-1827 12 S.

  Publikation: Beiträge in Fachzeitschriften › Zeitschriftenaufsätze › Forschung › Begutachtung

  • CD40 Ligand 100%
  • Inflammatory Bowel Diseases 76%
  • Epithelial Cells 57%
  • Mucous Membrane 24%
  • Ulcerative Colitis 19%
  32 Zitate (Scopus)
• 2009

  Cyclical expression of L-selectin (CD62L) by recirculating T cells

  Klinger, A., Gebert, A., Bieber, K., Kalies, K., Ager, A., Bel, E. B. & Westermann, J., 08.04.2009, in: International Immunology. 21, 4, S. 443-455 13 S.

  Publikation: Beiträge in Fachzeitschriften › Zeitschriftenaufsätze › Forschung › Begutachtung

  • L-Selectin 100%
  • T-Lymphocytes 45%
  • Lymph Nodes 19%
  • sulfated glycoprotein p50 13%
  • Ligands 9%
  17 Zitate (Scopus)
• 2006

  Hyperbaric oxygen reduces basal lamina degradation after transient focal cerebral ischemia in rats

  Veltkamp, R., Bieber, K., Wagner, S., Beynon, C., Siebing, D. A., Veltkamp, C., Schwaninger, M. & Marti, H. H., 03.03.2006, in: Brain Research. 1076, 1, S. 231-237 7 S.

  Publikation: Beiträge in Fachzeitschriften › Zeitschriftenaufsätze › Forschung › Begutachtung

  • Transient Ischemic Attack 100%
  • Basement Membrane 89%
  • kalinin 89%
  • Matrix Metalloproteinase 9 65%
  • Oxygen 64%
  35 Zitate (Scopus)
• 2005

  Hyperbaric oxygen reduces blood-brain barrier damage and edema after transient focal cerebral ischemia

  Veltkamp, R., Siebing, D. A., Sun, L., Heiland, S., Bieber, K., Marti, H. H., Nagel, S., Schwab, S. & Schwaninger, M., 01.08.2005, in: Stroke. 36, 8, S. 1679-1683 5 S.

  Publikation: Beiträge in Fachzeitschriften › Zeitschriftenaufsätze › Forschung › Begutachtung

  • Transient Ischemic Attack 100%
  • Blood-Brain Barrier 88%
  • Edema 74%
  • Oxygen 64%
  • Permeability 29%
  114 Zitate (Scopus)